Changes in markers of coagulation and inflammation in patients with pediatric severe sepsis treated with drotrecogin alfa (activated)

被引：0
|
作者：
Nadel, S
Williams, MD
Wang, DZ
Yan, SC
Planquois, JM
Giroir, B
机构：
[1] Imperial Coll Sch Med, London, England
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] DARPA, Arlington, VA USA
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00537
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A153 / A153
页数：1
相关论文
共 50 条
  • [1] The safety of drotrecogin alfa (activated) in pediatric patients with severe sepsis
    Goldstein, B
    Williams, M
    Wang, DZ
    Angle, R
    Giroir, B
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [2] Management of patients with severe sepsis, treated by drotrecogin alfa (activated)
    Laterre, PF
    Heiselman, D
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 39S - 46S
  • [3] Markers of outcome in patients with severe sepsis treated using drotrecogin alfa
    Chawla, Rajesh
    Kansal, S.
    Lall, A.
    Kanwar, M. S.
    Rosha, D.
    Bansal, A.
    Sikri, V.
    [J]. CHEST, 2007, 132 (04) : 555S - 555S
  • [4] Patterns of survival in patients with severe sepsis treated with drotrecogin alfa (activated)
    Williams, MD
    Macias, W
    Nelson, D
    [J]. CHEST, 2004, 126 (04) : 723S - 723S
  • [5] Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)
    Levi, Marcel
    Levy, Mitchell
    Williams, Mark D.
    Douglas, Ivor
    Artigas, Antonio
    Antonelli, Massimo
    Wyncoll, Duncan
    Janes, Jonathan
    Booth, Frank V.
    Wang, Dazhe
    Sundin, David P.
    Macias, William L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (05) : 483 - 490
  • [6] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [7] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [8] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    G Russo
    M La Spina
    N Disma
    M Astuto
    [J]. Bone Marrow Transplantation, 2006, 38 : 575 - 576
  • [9] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [10] Drotrecogin alfa (activated) in severe sepsis
    Janes, Jonathan M.
    Vangerow, Burkhard
    Costigan, Timothy M.
    Macias, William L.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
12345